Purple Biotech (PPBT) Long-Term Investments (2021 - 2025)
Purple Biotech's Long-Term Investments was $326,000 in Q2 2025, compared with $22,000 a year earlier and down 30.5% from the prior quarter.
Powered by 
Analysis
Purple Biotech (PPBT) Long-Term Investments (2021 - 2025) Analysis & Trends
At the end of FY2024, Long-Term Investments at Purple Biotech came in at $275,000, up 276.7% from FY2023.
- Long-Term Investments shows a three-year compound annual growth rate of 13.7% (FY2021 to FY2024).
- In earlier years, Long-Term Investments was $73,000 in FY2023 (-83.1%), $431,000 in FY2022 (+130.5%) and $187,000 in FY2021.
- Quarterly Long-Term Investments has moved between $14,000 (Q3 2024) and $469,000 (Q1 2025) over five years.
- Compared with a year earlier, Long-Term Investments was higher in 1 of the last six quarters, with an average decline of 18.5%.
- The best year-over-year quarter for Long-Term Investments over five years was Q4 2024 (growth of 276.7%); the worst was Q1 2024 (a decline of 94.6%).
- Per Business Quant data, PPBT's Long-Term Investments in the three quarters before Q2 2025 was $469,000 (Q1 2025), $275,000 (Q4 2024) and $14,000 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Purple Biotech | 249,214.64 | 191,214.64 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 326,000.00 |
| Mar 31, 2025 | 469,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Sep 30, 2023 | 138,000.00 |
| Jun 30, 2023 | 352,000.00 |
| Mar 31, 2023 | 386,000.00 |
| Dec 31, 2022 | 431,000.00 |
| Sep 30, 2022 | 187,000.00 |
| Jun 30, 2022 | 187,000.00 |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | 187,000.00 |
API Access
Purple Biotech Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();